Plasma metabolomics identifies key metabolites and improves the prediction of benign prostatic hyperplasia
These findings highlight the associations between circulating metabolites and the hazard of BPH, supporting the potential of NMR-based metabolomics to enhance risk prediction and inform clinical management strategies.
Authors
- Dingwen Liu
- Yong Li (ORCID: https://orcid.org/0000-0003-4038-0493)
- Yichuan Wang (ORCID: https://orcid.org/0000-0003-1575-0245)
- Ling Zhou (ORCID: https://orcid.org/0009-0008-8592-3870)
- Jie Li (ORCID: https://orcid.org/0000-0002-4366-7724)
- Jiaming He
- Long Wang
- Qing Zhou
- Xinkai Pan
Institutions
- Central South University (CN)
- First Affiliated Hospital of Hunan University of Traditional Chinese Medicine (CN)
- Third Xiangya Hospital (CN)
Publication Details
- Journal
- International Journal of Surgery
- Published
- 2026-02-12
- DOI
- https://doi.org/10.1097/js9.0000000000004929
- Primary Topic
- Metabolomics and Mass Spectrometry Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00